Oncimmune Holdings PLC (LSE:ONC) - Share price - Overview

Stock Report

Oncimmune Holdings PLC ONC

Last Price
GBX145.00

Day Change
0.50|0.35%

As of 19/02/2018
08:56:13 GMT | GBX
Minimum 15 Minutes Delay.

Last Close144.50p
Day Range145.00 - 145.00
Mkt Cap86.27Mil
52-Wk Range100.00 - 150.00
Yield %0.00
ISINGB00BYQ94H38
Volume10,000
P/E-14.74
P/S344.42
P/CF-17.29

Share Price

Total Returns 16/02/2018

 Chg (%)  
More ...
Oncimmune Holdings PLC13.33 
FTSE 100 TR GBP-5.59
 
Financials
201520162017
More ...
Income Statement
Turnover1.350.430.22
Operating Profit-1.38-5.71-5.27
Net Profit-2.01-8.44-5.02
Reported EPS-3.95-23.54-9.84
Balance Sheet
Current Assets1.8710.825.66
Non Current Assets0.080.380.75
Total Assets1.9511.216.41
Current Liabilities1.641.081.40
Total Liabilities5.771.481.40
Total Equity-3.829.735.00
Cash Flow
Operating Cash Flow-1.40-3.75-4.62
Net Change in Cash-0.318.93-5.09
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2018-4.20-5.30--27.27---
2019-1.30-2.20--65.68---

Company Profile

Oncimmune Holdings PLC is a cancer detection company engaged in developing and commercializing its proprietary EarlyCDT platform technology. Its product EarlyCDT-Lung is a simple blood test to aid the risk assessment and early detection of lung cancer.

Sector

Diagnostics & Research

Market Position

960 of 1830 Companies

Index

FTSE AIM All Share

Outlook

(13/02/2018) "...the board is increasingly confident that the company is well placed to execute that plan and deliver value in the medium and long term"

Next Event 31/05/2018

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-46.8714.5615.99
Div Yld (E)0.004.214.23
PEG (E)0.000.140.56
ROCE-105.19177.7417.78
Op Mrgn-2,452.56-2.130.88
EPS Grwth0.0045.0219.38
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Meinhard Schmidt
Chief Executive OfficerMr. Geoffrey Hamilton-Fairley
Chief Financial Officer & Company SecretMr. Andrew Millet
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.